The Current Priorities of BPOG’s Microbial Control Workstream

An exclusive interview with Brian Bell, Manager of the Process Microbiology Group at Bristol-Myers Squibb

The BPOG group is a collaboration of industry partners to discuss contemporary issues and challenges that we face but don’t compete against. There are areas where we can share our knowledge and learn from each other but they don’t interfere with our overall competitions in the marketplace.

The microbial control workstream started in 2012, with about 6-8 member companies, now has 23 member companies and almost 100 representatives. Meeting once a year, they discuss contemporary issues that are facing drug substance manufacturing for microbial attributes.

Hear the exclusive insights Brian Bell on the microbial control workstream now…

Leave a Reply